Wang, Z., Li, W., Ge, S., Jin, X., Xu, T., Li, J., Shen, L. (2026). A phase Ib, open-label, clinical trial of JAB21822 combined with second-line chemotherapy for metastatic colorectal cancer with KRAS G12C mutation.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3544